The Annexure

News to 9 October 2026 ·

What the ground filed.

A desk of BSE disclosures — every listed company, sliced the way you need it.

Data as of 9 October 2026

Fundraising

The Board of Directors of the Company Evonile Pharma Limited (formally known as Novartis India Limited) approved the raising of funds by way of Rights Issue at their Board Meeting held ....

The filing

The Board of Directors of the Company Evonile Pharma Limited (formally known as Novartis India Limited) approved the raising of funds by way of Rights Issue at their Board Meeting held ....

Company
Novartis India Ltd · BSE 500672
Filed
8 October 2026, 19:10 IST
BSE category
Company Update / Raising of Funds
Tag
Fundraising · selected
Source
Open the filing on BSE →

Why it led

  • First Fundraising from this company — not seen in the 93 trading days on record
  • Micro cap
  • 3 filings today

Selected by the ranker from 41 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

333 of 90,553 filings in the published window carry Fundraising · 0.37%

Around it

Also filed by Novartis India Ltd on 8 October 2026

Most recent filings from Novartis India Ltd

The company

Novartis India Ltd

BSE 500672 · NSE NOVARTIND · ISIN INE234A01025 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

Full figures, price and filing history for Novartis India Ltd →